Blog - QualityStocks

TuesdayOct 13, 2026 10:20 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Announces MindWave NILA Token Listing on Pionex Exchange

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that NILA, the native utility and governance token of the MindChain network developed by its wholly owned subsidiary, MindWave Innovations Inc. USA, is scheduled to begin trading on the Pionex cryptocurrency exchange Oct. 14, 2026, at 6 a.m. Eastern time. The listing will make NILA available to eligible users through the NILA/USDT trading pair, with access to Pionex's standard trading features and automated trading tools. The listing expands international access to NILA ahead of its planned migration to MindChain, an Ethereum-based Layer 2 network designed to support enterprise blockchain applications. MindWave has…

TuesdayOct 13, 2026 9:20 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Sponsors Ukrainian Defense Tech Pavilion Reception at AUSA 2026

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0), a defense technology company delivering positioning in GPS-denied environments, announced its sponsorship of the Ukrainian Defense Tech Pavilion Reception at the Association of the United States Army (AUSA) 2026 Annual Meeting & Exposition, taking place Oct. 12-14 in Washington, D.C. The company's U.S. leadership team will attend the exposition to meet with military officials, allied partners and defense industry stakeholders regarding its Overwatch Positioning Network, which provides positioning and targeting capabilities for uncrewed systems operating without…

TuesdayOct 13, 2026 9:10 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo proof-of-concept data and additional in vitro findings validating its BiTAC-ADC technology platform at the 17th World ADC Congress in San Diego. The in vivo study demonstrated significant tumor regression in a breast cancer model following a single 3 mg/kg dose, with no observed decrease in body weight. The results also showed that both BiTAC-ADC components were required to produce the intended tumor-specific response. Additional in vitro studies demonstrated the platform's ability to distinguish cancer cells from healthy cells, prevent the release of active…

TuesdayOct 13, 2026 9:00 am

QualityStocksNewsBreaks – IBNAi Launches IBNAi Wallet, Surpassing 64,000 New Wallets in Five Days

InvestorBrandNetwork AI (IBNAi), a leader in AI-powered financial communications and capital markets solutions, announced the successful launch of its IBNAi Wallet, with more than 64,000 new wallets created in the first five days, averaging more than 12,000 per day. Developed in collaboration with Dynamic and supported by a strategic partnership with Fireblocks, the enterprise-grade, non-custodial wallet is designed to provide secure, streamlined access to the company's digital asset ecosystem for corporate issuers, business clients and community participants holding the native $IBNAi utility token. The wallet features email and passkey authentication, multi-party computation security, multi-chain token transfers, on-chain transaction tracking and…

MondayOct 12, 2026 1:55 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Reports Strong Surgeon Interest in GelrinC at International Cartilage Summit

Regentis Biomaterials (NYSE American: RGNT), a regenerative medicine company focused on innovative tissue repair solutions, announced strong interest and engagement from orthopedic surgeons, physicians and cartilage repair specialists at the 8th International Cartilage Regeneration & Joint Preservation Society ("ICRS") Summit, held Oct. 8-10 in Porto, Portugal. Discussions focused on GelrinC(R), the company's CE Mark-approved, cell-free hydrogel implant designed to regenerate damaged knee cartilage through a single procedure lasting approximately 10 minutes. In a Phase II study, GelrinC demonstrated approximately 100% greater improvement in overall Knee Injury and Osteoarthritis Outcome Score ("KOOS") scores compared with historical microfracture controls at two years,…

MondayOct 12, 2026 9:45 am

American Fusion(TM) Inc. (AMFN) Details Texatron(TM) Fusion Program Plasma Compression and Confinement Approach

A technical analysis by CTO Dr. John E. Brandenburg examines the use of short, high-power magnetic pulses to compress and heat toroidal plasma. A rifled toroidal chamber is intended to shape the magnetic field and help organize the plasma during compression. Earlier low-temperature experiments are cited as support for further testing of the confinement concept, but they did not demonstrate fusion-temperature confinement or fusion power. The company is developing Texatron(TM) around deuterium and helium-3 fuel and a proposed direct magnetic-to-electric conversion approach. Fusion ignition, net energy gain and commercial electricity generation remain development objectives requiring further experimental validation. American Fusion(TM)…

MondayOct 12, 2026 9:20 am

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15

Regentis Biomaterials (NYSE American: RGNT), a regenerative medicine company focused on innovative tissue repair solutions, announced that CEO and Executive Chairman Ehud Geller will present at the 2026 ThinkEquity Conference on Oct. 15, 2026, at 10 a.m. at the Mandarin Oriental Hotel in New York City. Geller will provide an overview of the company’s GelrinC(R) technology, recent clinical developments, progress in its ongoing U.S. Food and Drug Administration ("FDA") pivotal Phase III trial and preparations for commercialization in Europe, where GelrinC has received CE Mark approval. Geller and Chief Financial Officer Ori Gon will also be available for one-on-one meetings…

MondayOct 12, 2026 9:10 am

QualityStocksNewsBreaks – InvestorNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML; FSE: HK6) Welcomes EU Strategic Project Designation for Neo Performance Materials Silmet 2.0

Greenland Mines (NASDAQ: GRML; FSE: HK6), a critical-minerals developer advancing two major projects in Greenland, welcomed the European Commission’s selection of Neo Performance Materials Silmet 2.0 development plan as one of 46 new Strategic Projects under the European Union’s Critical Raw Materials Act ("CRMA"). Announced Oct. 9, 2026, the designation supports efforts to strengthen and diversify European critical-mineral supply chains. Neo, a strategic shareholder in Greenland Mines with offtake rights for up to 60% of future production from the Sarfartoq Project, plans to adapt its rare earth separation facility in Estonia to accommodate new raw material sources. Greenland Mines views…

MondayOct 12, 2026 9:00 am

Versus Systems Inc. (NASDAQ: VS) Names Brian Goldenberg CFO to Further Strengthen Financial and Operational Infrastructure

Goldenberg brings more than 25 years of financial and operational leadership experience. He will also serve as the company’s principal financial officer and principal accounting officer. His background includes CFO, COO, and chief compliance officer roles at investment management firms. The appointment comes as Versus develops its gamification and audience engagement business across digital and live environments. Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has appointed Brian Goldenberg, CPA, as chief financial officer, adding a senior executive with more than 25 years of finance and operations experience. Goldenberg’s appointment took effect September 8, 2026.…

MondayOct 12, 2026 9:00 am

QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Three Blockchain Network Agreements Across Three Industries

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc. USA, announced that MindWave signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks on its MindChain infrastructure for clients in climate finance, sports media and insurance. The agreements include Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the agreements, MindWave will receive contracted fees or equity along with allocations…

Site Search

Company Search